home / stock / igx:cc / igx:cc news

IGX:CC News and Press, Intelgenx Technologies Corp.

Stock Information
Company Name: Intelgenx Technologies Corp.
Stock Symbol: IGX:CC
Market: TSXC
Website: intelgenx.com
Menu
IGX:CC IGX:CC Quote IGX:CC Short IGX:CC News IGX:CC Articles IGX:CC Message Board
Get IGX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
IGX:CC - IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process

MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OTC: IGXT) , a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announced today that the Pha...
IGX:CC - IntelGenx Obtains Preliminary Efficacy Results for the 'BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease

MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA Alzheimer’s disease (AD) study. The BUENA study was designed as ...

IGX:CC - IntelGenx Announces Initiation of the Sale and Investment Solicitation Process

MONTREAL, June 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “ Company ” or “ IntelGenx ” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), was granted protection pursuant to an order (as amended or amended and restated from time t...

IGX:CC - IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process

MONTREAL, May 28, 2024 (GLOBE NEWSWIRE) -- As previously announced on May 17, 2024, IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing o...
IGX:CC - IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives

MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announced today that i...

IGX:CC - Canadian Investment Regulatory Organization Trading Halt - IGX

Canadian Investment Regulatory Organization Trading Halt - IGX Canada NewsWire TORONTO , May 17, 2024 /CNW/ - The following issues have been halted by CIRO: Company: IntelGenx Technologies Corp. TSX Symbol: IGX All Issues: Yes Reason: Pending News ...

IGX:CC - Expected Canadian Company Earnings on Thursday, May 9th, 2024

Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...
IGX:CC - Expected earnings - IntelGenx Technologies Corp.

IntelGenx Technologies Corp. (IGX:CA) is expected to report for Q1 2024

IGX:CC - IntelGenx Announces Voting Results on Election of Directors

SAINT LAURENT, Quebec, May 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “ Company ” or “ IntelGenx ”) announces that, at the annual meeting of shareholders of the Company held on May 7, 2024 (the “ A...

IGX:CC - IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent

SAINT LAURENT, Quebec, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office (“USPTO”) has granted a Notice of Allowanc...
Next 10